Wedbush Securities’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,455	Closed	-$269K	–	1261
2023 Q4	$269K	Buy	4,455 +329	+8%	+$19.9K	0.01%	821
2023 Q3	$235K	Sell	4,126 -2,764	-40%	-$157K	0.01%	840
2023 Q2	$351K	Buy	+6,890	New	+$351K	0.02%	682